BYL719
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for BYL719, covering 2017-11-13 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719 [NA]